Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06695156 · ClinicalTrials.gov registry record · NA

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study

A NA study of Migraine and Migraine With or Without Aura, sponsored by Maharishi International University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06695156 is a NA study of Migraine and Migraine With or Without Aura that is active but no longer recruiting, run by Maharishi International University. The registered enrollment target is 30 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06695156, a NA study of Migraine and Migraine With or Without Aura, is active but no longer recruiting, sponsored by Maharishi International University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

Interventions

  • BEHAVIORAL Meditation

Study Locations (1)

District of Columbia

  • Georgetown Headache Center and DC area - Washington D.C.

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-08-28
Est. Completion 2026-05
Phase NA

What the Registry Record Tells You About NCT06695156

The ClinicalTrials.gov registry entry for NCT06695156 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (92% lower). The listed sponsor is Maharishi International University, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Meditation is the first listed.

NCT06695156 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06695156 about?

NCT06695156 is a clinical study titled "Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: A Single Arm Study". This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

What is the current status of trial NCT06695156?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-28. Estimated completion is 2026-05.

What conditions does trial NCT06695156 study?

This clinical trial studies the following conditions: Migraine, Migraine With or Without Aura.

What interventions are being tested in trial NCT06695156?

The interventions under investigation include: Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06695156?

This trial is sponsored by Maharishi International University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06695156 being conducted?

This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.